Gísli Jenkins - Concepedia

Author

Gísli Jenkins

Also Known As

A B Docherty, B Card, B. Jayaraman, BL Yaspan, Brian L. Yaspan, E R Chilvers, G JENKINS, G Jenkins, G Jenkins (7694360), G. Jenkins

483

Publications

21.5K

Citations

H-Index

150

Concepts

All Affiliations

University of Nottingham Imperial College London Nottingham Biomedical Research Centre University of Leicester University College London

About

Gísli Jenkins is an author at University of Nottingham specializing in medicine, lung inflammation, and inflammatory lung disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	35	3.7K
2	Public Health	6	6	787
3	Engineering	2	2	66
4	Health Sciences	2	2	48
5	Natural Sciences	1	1	27

Gísli Jenkins

114

Publications

13.8K

Citations

H-Index

Page 1

	Year	Citations
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline Ganesh Raghu, Martine Rémy‐Jardin, Jeffrey L. Myers, American Journal of Respiratory and Critical Care Medicine	2018	3.9K
Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals David J. Lederer, Scott C. Bell, Richard D. Branson, Annals of the American Thoracic Society Quasi-experimentCausal InferenceCritical Care MedicineBiasClinical Epidemiology	2018	697
Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study Rachael A Evans, Hamish McAuley, Ewen M. Harrison, The Lancet Respiratory Medicine	2021	636
The rising incidence of idiopathic pulmonary fibrosis in the UK Vidya Navaratnam, Kate M. Fleming, Joe West, Thorax	2011	482
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study Rachael A Evans, Olivia C. Leavy, Matthew Richardson, The Lancet Respiratory Medicine	2022	407
An Official American Thoracic Society Workshop Report: Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosis Gísli Jenkins, Bethany B. Moore, Rachel C. Chambers, American Journal of Respiratory Cell and Molecular Biology Potential TherapiesAntifibrotic TherapyInflammatory Lung DiseaseAdvanced Lung DiseaseLung Inflammation	2017	404
Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis Richard J. Allen, Beatriz Guillén‐Guío, Justin M. Oldham, American Journal of Respiratory and Critical Care Medicine	2019	323
Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study Gísli Jenkins, Juliet K. Simpson, Gauri Saini, The Lancet Respiratory Medicine FibrosisAdvanced Lung DiseasePathologyBiomarkersPulmonary Fibrosis	2015	316
Ligation of protease-activated receptor 1 enhances v 6 integrin-dependent TGF- activation and promotes acute lung injury Gísli Jenkins Journal of Clinical Investigation Acute Lung InjuryInflammatory Lung DiseaseLung InflammationImmunologyProtease-activated Receptor 1	2006	310
Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study Richard J. Allen, Joanne Porte, Rebecca Braybrooke, The Lancet Respiratory Medicine	2017	294

Page 1